Akero Therapeutics, Inc. (AKRO) Social Stream
AKERO THERAPEUTICS INC (AKRO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AKRO.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 7 | $64 | $27 | $48 | $22.58 | 112.58% |
| 2021-11-15 | 7 | $62 | $29 | $48 | $22.58 | 112.58% |
| 2021-12-22 | 7 | $62 | $29 | $47.571 | $22.58 | 110.68% |
| 2022-02-25 | 7 | $62 | $26 | $47.142 | $22.58 | 108.78% |
| 2022-02-28 | 6 | $62 | $26 | $46 | $22.58 | 103.72% |
| 2022-05-09 | 4 | $62 | $26 | $47.5 | $22.58 | 110.36% |
| 2022-08-08 | 5 | $62 | $26 | $40.75 | $22.58 | 80.47% |
| 2022-09-14 | 5 | $62 | $30 | $43.4 | $22.58 | 92.21% |
| 2022-10-03 | 5 | $62 | $30 | $44.4 | $22.58 | 96.63% |
| 2022-10-07 | 5 | $62 | $30 | $48 | $22.58 | 112.58% |
| 2022-11-04 | 5 | $62 | $40 | $50 | $22.58 | 121.43% |
| 2022-11-07 | 5 | $64 | $40 | $50.4 | $22.58 | 123.21% |
| 2022-12-20 | 5 | $64 | $40 | $52.4 | $22.58 | 132.06% |
| 2023-01-27 | 4 | $65 | $48 | $57.4 | $22.58 | 154.21% |
| 2023-03-20 | 5 | $65 | $48 | $57.4 | $22.58 | 154.21% |
| 2023-04-03 | 6 | $65 | $48 | $57.5 | $22.58 | 154.65% |
| 2023-05-16 | 7 | $70 | $48 | $59 | $22.58 | 161.29% |
| 2023-06-07 | 7 | $70 | $48 | $59.285 | $22.58 | 162.56% |
| 2023-08-14 | 7 | $70 | $48 | $59.714 | $22.58 | 164.46% |
| 2023-09-05 | 8 | $83 | $50 | $64.375 | $22.58 | 185.1% |
| 2023-09-14 | 8 | $83 | $58 | $67.375 | $22.58 | 198.38% |
| 2023-09-19 | 9 | $83 | $58 | $67.555 | $22.58 | 199.18% |
| 2023-09-25 | 9 | $83 | $58 | $68.333 | $22.58 | 202.63% |
| 2023-10-03 | 9 | $105 | $58 | $71.666 | $22.58 | 217.39% |
| 2023-10-10 | 9 | $105 | $33 | $67.555 | $22.58 | 199.18% |
| 2023-10-11 | 9 | $83 | $33 | $51 | $22.58 | 125.86% |
| 2023-10-12 | 9 | $60 | $33 | $43.444 | $22.58 | 92.4% |
| 2023-11-13 | 9 | $60 | $33 | $44 | $22.58 | 94.86% |
| 2023-11-15 | 9 | $60 | $33 | $42.75 | $22.58 | 89.33% |
| 2023-12-26 | 9 | $60.001 | $33 | $42.75 | $22.58 | 89.33% |
The Trend in the Analyst Price Target
Over the past 23 months, AKRO's average price target has gone down $4.39.
AKRO reports an average of 76.22% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-21 | 6 | 65 | 48 | 57.500 | 37.27 | 54.28% |
| 2023-04-26 | 7 | 70 | 48 | 59.285 | 44.59 | 32.96% |
| 2023-08-14 | 7 | 70 | 48 | 59.714 | 47.36 | 26.09% |
| 2023-08-14 | 7 | 70 | 49 | 59.857 | 47.36 | 26.39% |
| 2023-10-12 | 9 | 60 | 33 | 43.444 | 14.69 | 195.74% |
AKRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 9 | 0 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
AKRO's average broker recommendation rating improved by 0.4 over the prior 15 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AKRO as an investment opportunity.
- In the context of all US stocks, AKERO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 3051.35% of them.
- AKERO THERAPEUTICS INC's variance in analysts' estimates is lower than -2271.36% of all US stocks.
- In the context of Pharmaceutical Products stocks, AKERO THERAPEUTICS INC's average analyst price target is greater than 2596.29% of them.
- AKERO THERAPEUTICS INC's number of analysts covering the stock is higher than 1503.92% of stocks in the mid market cap category.
Stocks similar to AKERO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are STOK, NGM, and ARVN.
View All Top Stocks by Price Target
Is AKRO a Buy, Hold or Sell? See the POWR Ratings now!